SOBI-006

N/A

Report date: 2025/01/26 15:40:21

Base Information

Drug NameSOBI-006

Drug Alias NameIL-1 Inhibitor (SOBI)SOBI-006

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionInterleukin-1 receptor antagonists

TargetsInterleukin-1 receptor

Therapy Area/IndicationsInflammation

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySweden

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSwedish Orphan Biovitrum Ab (Publ)

China Registration ClassN/A

Develop Information

Active CompaniesSwedish Orphan Biovitrum Ab (Publ)

Inactive CompaniesN/A

Active IndicationsInflammation

Inactive IndicationsN/A

Other Information

ATC CodeN/A